Protein kinase C as a molecular target for cancer prevention by selenocompounds

Nutrition and Cancer

Volumn 40, Issue 1, 2001, Pages 55-63

  Gopalakrishna, R ^a   Gundimeda, U ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; PROTEIN KINASE C; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CANCER STAGING; DRUG MECHANISM; ENZYME INACTIVATION; HUMAN; METASTASIS; OXIDATION REDUCTION REACTION; PROMOTER REGION; PROTEIN DOMAIN; REVIEW;

EID: 0035674060     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC401_11     Document Type: Review

References (134)

1. The epidemiology of selenium and cancer
2. Relationship of selenium to cancer-inhibitory effect of selenium against carcinogenesis
3. Chemopreventive agent: Selenium
4. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
5. Factors influencing the inhibitory effect of selenium on mice inoculated with Erlich ascites tumor cells
6. Changes in cellular glutathione levels: Possible relation to selenium-mediated anticarcinogenesis
7. Current ideas on selenium as a chemopreventive agent
8. Activity of methylated forms of selenium in cancer prevention
9. Selenium and mouse mammary tumorigenesis: An investigation of possible mechanisms
10. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis
11. Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status
12. Effects of combined treatment with selenium, glutathione, vitamin E on glutathione peroxidase activity, omithine decarboxylase inuction and complete multistage carcinogenesis in mouse skin
13. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin
14. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
15. Selenium and prostate cancer prevention
16. Influence of N-methyl-N-nitrosourea, testosterone and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats
17. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
18. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone
19. Selective effects of selenium selenite on 7, 12-dimethylbenz[a]anthracene DNA binding in fetal mouse cell cultures
20. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms of action
21. Screening potential chemopreventive agents using biochemical markers of carcinogenesis
22. The effect of sodium selenite on cell proliferation and transformation of primary rat tracheal epithelial cells
23. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: Its role in inhibition of tumor promotion
24. Effect of selenite on tumor cell invasiveness
25. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice
26. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake
27. Mechanisms of selenium inhibition of tumorigenesis
28. Differential induction of growth arrest inducible genes by selenium compounds
29. Chemoprevention of prostate cancer: Concepts and strategies
30. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer
31. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat
32. Selenium-mediated inhibition of mouse mammary tumorigenesis
33. Dietary selenium intake and growth of the MT-W 9B transplantable rat mammary tumor
34. Inhibition of human breast cancer cells by selenium
35. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line
36. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L 1210 cells
37. Effects of organic and inorganic selenium compounds on rat mammary tumor cells
38. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29)
39. 2 toxicity
40. Prevention of exudative diathesis in chicks by factor 3 and selenium
41. Regulation of selenoproteins
42. Molecular biology of selenoproteins
43. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene
44. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties and thioredoxin reductase activity
45. Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells
46. Effect of selenium on rat thioredoxin reductase actvity
47. Thioredoxin reductase activity is decreased by selenium deficiency
48. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium
49. Selenite and selenate inhibit human lymphocyte growth via different mechanisms
50. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo
51. Thioredoxin reductase mediates cell death effects of the combination of β-interferon and retinoic acid
52. Thioredoxin, a mediator of growth inhibition maps to 9q31
53. On the nature of selenium toxicity and carcinostatic activity
54. Studies of the role of DNA fragmentation in selenium toxicity
55. Adaptive changes in hepatic glutathione metabolism in response to excess selenium in rats
56. Selenium inhibition of DNA synthesis in mouse mammary epithelial cell line YN-4
57. Differential effects of selenium on normal and neoplastic canine mammary cells
58. Differential effects of selenium on the growth of mouse mammary cells in vitro
59. Evidence for the involvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite
60. Metabolism of subtoxic levels of selenium in animals and humans
61. Considerations in the design of selenium bioavailability studies
62. Function of erythrocytes in attaching selenite-Se onto specific plasma proteins
63. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
64. Involvement of polyamines in selenomethionine-induced apoptosis and mitotic alteration in human tumor cells
65. Effect of dietary methionine on utilization of tissue selenium from dietary selenomethionine from glutathione peroxidase in the rat
66. Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma
67. Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma
68. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
69. Protein kinase C and tumor promoters
70. Complexities of the protein kinase C pathway
71. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of regulatory domain
72. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate
73. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells
74. Activation of hepatocyte protein kinase C by redox-cycling quinones
75. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure of mouse epidermal cells to oxidants
76. Redox control of gene expression by eukaryotic transcription factors NF-KB, AP-1 and SRF/TCF
77. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and α-tocopherol in vascular smooth muscle cells
78. Mechanism of c-fos induction by active oxygen
79. Association of protein kinase C activation with induction of omithine decarboxylase in murine but not human keratinocyte cultures
80. min mice
81. Protein kinase C signaling and oxidative stress
82. Modification of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and the enzyme-specific inhibitors
83. The regulatory domain of protein kinase C coordinates four atoms of zinc
84. Residues in the second cysteine-rich region of protein kinase C relevant to phorbol ester binding as revealed by site-directed mutagenesis
85. Activation of rat brain protein kinase C by lipid oxidation products
86. Lipoxygenase metabolites of arachidonate and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C
87. Effect of linoleic acid hydroperoxide on endothelial cell calcium homeostasis and phospholipid hydrolysis
88. Reversible inactivation of protein kinase C by oltipraz through reaction with the catalytic domain: Role in inhibition of tumor promotion
89. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells
90. Curcumin irreversibly inactivates protein kinase C activity and phorbol ester binding: Its possible role in cancer chemoprevention
91. Inhibition of cell prolifration by α-tocopherol: Role of protein kinase C
92. Vitamin E succinate inhibits protein kinase C: Correlation with its unique inhibitory effects on cell growth and transformation
93. 2+-dependent isoenzymes of protein kinase C
94. Effects of methylselenocysteine on PKC activity, cdk 2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells
95. Selenotrisulfides. II. Cross-linking of reduced pancreatic ribonuclease with selenium
96. Chemoprevention of cancer by organoselenium compounds
97. Inhibition of thymidine kinase in cultured mammary cells by the chemopreventive organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate
98. Inhibition of PKC and PKA by chemopreventive organoselenium compounds
99. Activity of methylated forms of selenium in cancer prevention
100. Novel biologically active seleno-organic comound. II. Activity of PZ 51 in relation to glutathione peroxidase
101. Studies on the anti-inflammatory activity of ebselen: Ebselen intereferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C
102. Redox-active chalcogencontaining glutathione peroxidase mimetics and antioxidants inhibit tumor promoter-induced downregulation of gap junctional intercellular communication between WBF 344 liver epithelial cells
103. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite
104. Selenoprotein thioredoxin reductase activates the oxidized protein kinase C by a direct interaction with its zinc-thiolates
105. Hyperoxia, unlike phorbol ester, induces glutathione peroxidase through a protein kinase C-independent mechanism
106. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters
107. Thioredoxin reductase is the major selenoprotein expressed in human umbilical vein endothelial cells and is regulated by protein kinase C
108. Stimulation of lipid peroxidation in vivo by injecting selenite and lack of stimulation by selenite
109. 75Se
110. Protective effects of zinc on cultured rat primary hepatocytes to metals with low affinity for metallothionein
111. Enhanced sensitivity of oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes
112. Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats
113. Mammary cancer chemoprevention by inorganic and organic selenium: Single agent treatment or in combination with vitamin E and their effects on in vitro immune functions
114. Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes
115. Inhibition of cell proliferation by α-tocopherol: Role of protein kinase C
116. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin
117. AP-1 DNAbinding activity is inhibited by selenite and selenodiglutathione
118. Inhibition of NF-KB DNA binding and nitric oxide induction in human T cells and lung carcinoma cells by selenite treatment
119. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C
120. Loss of protein kinase C function induces a proapoptotic response
121. Functions of ceramide in coordinating cellular responses to stress
122. Ceramide signaling in apoptosis
123. Selenium-induced apoptosis in prostate cancer cells: Role of protein kinase C inactivation and ceramide generation (abstr)
124. The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release
125. Functional role for mitochondrial protein kinase C in Bcl 2 phosphorylation and suppression of apoptosis
126. The release of cytochrome c from mitochondria: A primary site of Bcl-2 regulation of apoptosis
127. Protein kinase C5 is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes
128. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis
129. 2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma
130. Protein kinase C inhibitor calphostin C inhibits B 16 melanoma metastasis
131. Protein kinase C δ involvement in mammary tumor cell metastasis
132. Inhibition of cell attachment by selenite
133. Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the citrus antioxidant auraptene on lung metastasis of melanoma cells in mice